Roland Thomas, MD
Surgical Critical Care · Valparaiso, INNPI 1356346027
Payments from drug & device makers
What this record shows
This record is dominated by education: $9,500 of the $12,576 with a category attached, or 75.5%. Intuitive Surgical accounts for 97.9% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $9,864 and has fallen 99.3% since, to $69 in 2025. Among surgical critical care clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 41 payments — averaging $306.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$12K
- AbbVie$108
- Davol Inc.$67
- Baxter Healthcare$59
- Phathom Pharmaceuticals, Inc.$18
- Gilead$17
What the payments were for
- Travel & lodging$1,85615%
- Food & beverage$1,21010%
- Education$9,50076%
- Gifts$90%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 32 | $12,307 |
| AbbVie | 4 | $108 |
| Davol Inc. | 2 | $67 |
| Baxter Healthcare | 1 | $59 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Gilead | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$9,500
- Da Vinci Surgical System$2,204
How this compares
$12,576 in reported general payments places this provider in the 90th percentile of 29 surgical critical care providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CholestyramineCholestyramine (With Sugar) | 29 | $1,068 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 81 | $332 |
| Tamoxifen Citrate | 12 | $325 |
| Levothyroxine Sodium | 13 | $187 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 37 | $129 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $87 |
| Tamsulosin Hcl | 18 | $86 |
| Metoclopramide Hcl | 21 | $84 |
| Gabapentin | 15 | $73 |
Paid to pharmacies, not to this prescriber.
Other surgical critical care in Valparaiso
- Jac CooperValparaiso$153
- Michael NemethValparaiso$148
- Daniel CozaddValparaiso$32
- Lawrence LottenbergFort Wayne$21K
- Timothy PohlmanFort Wayne$18K
- Rachael SpringerIndianapolis$12K
- Samantha TarrasIndianapolis$12K
- William PeeryFort Wayne$11K
- Zachary LaucisSouth Bend$9K
- Colin FathElkhart$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.